Supply Issues Aymes Nutritional Supplements ABX978 and ABX979 (ICN 3358)

• The supply issue with nutritional supplements from Aymes has improved.
• Three affected product codes are now available to order through our online catalogue:
  • ABX974 – Chocolate Shake 57g
  • ABX975 – Vanilla Shake 57g
  • ABX976 – Banana Shake 57g.
• Two product codes remain suspended and unavailable to order:
  • ABX978 – Strawberry Shake 57g
  • ABX977 – Savoury Vegetable 57g.
• Two products are now affected in total.
• Unfortunately, there are still no alternatives available. Customers are advised to view the online catalogue for products they deem suitable.
• See our Downloads ▼ section to access the product listing for further information on the affected product codes.
• The supply issue is now anticipated to be resolved by 30 October 2026.

Change:

• The supplier Aymes has informed us of a supply issue with its nutritional supplement products.
• There are five product codes affected:
  • ABX974 – Chocolate Shake 57g
  • ABX975 – Vanilla Shake 57g
  • ABX976 – Banana Shake 57g
  • ABX978 – Strawberry Shake 57g
  • ABX979 – Savoury Chicken 57g.
• The supply issue is due to supplier manufacturing issues.

 Impact:          

• All the affected product codes are currently suspended and unavailable to order.
• Unfortunately, there are no alternatives available. Customers are advised to view the online catalogue for products they deem suitable.
• See our Downloads ▼ section to access the product listing for further information on the affected product codes.
• The supply issue is anticipated to be resolved by 5 September 2026.

 Next Steps:               

• Customers are advised to log into our website to view the product listing for further information on the affected product codes.
• We will update the ICN when we have further information.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.

Please note that due to the clinical nature of these alternative products, we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.